Completion of radiotherapy for local and regional head and neck cancer in medicare.

Publication Type:

Journal Article


Archives of otolaryngology--head & neck surgery, Volume 135, Issue 9, p.860-7 (2009)


2009, Aged, Aged, 80 and over, Biopsy, Needle, Center-Authored Paper, Cohort Studies, Dose-Response Relationship, Radiation, Female, Head and Neck Neoplasms, Humans, Immunohistochemistry, Logistic Models, Male, Medicare, Neoplasm Invasiveness, Neoplasm Staging, Patient Compliance, Probability, Prognosis, Public Health Sciences Division, Radiotherapy Dosage, Radiotherapy, Adjuvant, Registries, Risk Assessment, SEER Program, Survival Analysis, Treatment Outcome, United States, Vaccine and Infectious Disease Institute


To identify factors associated with interruption or early discontinuation of treatment in patients receiving radiotherapy for head and neck cancer, because it is believed that such treatment interruption or early discontinuation increases the risk of disease relapse and adversely influences survival. Design, Setting, and